ES2211374T3 - Dosificacion metronomica de taxanos para inhibir el crecimiento tumoral. - Google Patents

Dosificacion metronomica de taxanos para inhibir el crecimiento tumoral. Download PDF

Info

Publication number
ES2211374T3
ES2211374T3 ES02723255T ES02723255T ES2211374T3 ES 2211374 T3 ES2211374 T3 ES 2211374T3 ES 02723255 T ES02723255 T ES 02723255T ES 02723255 T ES02723255 T ES 02723255T ES 2211374 T3 ES2211374 T3 ES 2211374T3
Authority
ES
Spain
Prior art keywords
taxane
dose
milliliters
tumor
paclitaxel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES02723255T
Other languages
English (en)
Spanish (es)
Other versions
ES2211374T1 (es
Inventor
Joseph Fargnoli
William C. Rose
Pamela Trail
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ES2211374T1 publication Critical patent/ES2211374T1/es
Application granted granted Critical
Publication of ES2211374T3 publication Critical patent/ES2211374T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Carpets (AREA)
ES02723255T 2001-02-28 2002-02-26 Dosificacion metronomica de taxanos para inhibir el crecimiento tumoral. Expired - Lifetime ES2211374T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27194401P 2001-02-28 2001-02-28
US271944P 2001-02-28

Publications (2)

Publication Number Publication Date
ES2211374T1 ES2211374T1 (es) 2004-07-16
ES2211374T3 true ES2211374T3 (es) 2007-03-01

Family

ID=23037749

Family Applications (1)

Application Number Title Priority Date Filing Date
ES02723255T Expired - Lifetime ES2211374T3 (es) 2001-02-28 2002-02-26 Dosificacion metronomica de taxanos para inhibir el crecimiento tumoral.

Country Status (31)

Country Link
EP (1) EP1372636B1 (https=)
JP (1) JP2004538253A (https=)
KR (1) KR20030086276A (https=)
CN (1) CN1533273A (https=)
AR (1) AR033609A1 (https=)
AT (1) ATE331511T1 (https=)
BG (1) BG108167A (https=)
BR (1) BR0207519A (https=)
CA (1) CA2439299A1 (https=)
CY (1) CY1105468T1 (https=)
CZ (1) CZ20032232A3 (https=)
DE (2) DE60212813T2 (https=)
DK (1) DK1372636T3 (https=)
EE (1) EE200300413A (https=)
ES (1) ES2211374T3 (https=)
HR (1) HRP20030775A2 (https=)
HU (1) HUP0402115A2 (https=)
IL (1) IL157356A0 (https=)
IS (1) IS6924A (https=)
MX (1) MXPA03007655A (https=)
NO (1) NO20033809L (https=)
PE (1) PE20020955A1 (https=)
PL (1) PL373376A1 (https=)
PT (1) PT1372636E (https=)
RU (1) RU2003129233A (https=)
SK (1) SK10332003A3 (https=)
TR (1) TR200400375T3 (https=)
UY (1) UY27185A1 (https=)
WO (1) WO2002067928A2 (https=)
YU (1) YU66603A (https=)
ZA (1) ZA200306450B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
PL2286794T3 (pl) * 2003-10-15 2016-10-31 Zastosowanie kationowych liposomów zawierających paklitaksel
JP5700909B2 (ja) * 2005-05-04 2015-04-15 メディゲーネ アクチエンゲゼルシャフトMediGene AG パクリタキセルを含む陽イオン性リポソーム製剤を投与する方法
MX2008011978A (es) 2006-03-22 2009-04-22 Medigene Ag Tratamiento del cancer de seno negativo al triple receptor.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100615783B1 (ko) * 1997-05-27 2006-08-25 아이박스 리서치 인코포레이티드 탁산 치료를 받고 있는 인체를 제외한 포유동물의 과민증 또는 알러지 반응을 경감시키기 위한 방법 및 약학적 키트
US6750246B1 (en) * 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US6362217B2 (en) * 2000-03-17 2002-03-26 Bristol-Myers Squibb Company Taxane anticancer agents

Also Published As

Publication number Publication date
DK1372636T3 (da) 2006-11-06
NO20033809D0 (no) 2003-08-27
SK10332003A3 (sk) 2005-03-04
ES2211374T1 (es) 2004-07-16
CA2439299A1 (en) 2002-09-06
CZ20032232A3 (en) 2004-06-16
BG108167A (en) 2004-09-30
JP2004538253A (ja) 2004-12-24
IL157356A0 (en) 2004-02-19
PE20020955A1 (es) 2002-10-30
ZA200306450B (en) 2004-11-19
DE60212813D1 (de) 2006-08-10
DE02723255T1 (de) 2004-07-15
WO2002067928A2 (en) 2002-09-06
TR200400375T3 (tr) 2004-04-21
WO2002067928A3 (en) 2003-10-09
EP1372636A2 (en) 2004-01-02
AR033609A1 (es) 2003-12-26
IS6924A (is) 2003-08-22
ATE331511T1 (de) 2006-07-15
YU66603A (sh) 2006-08-17
UY27185A1 (es) 2002-09-30
KR20030086276A (ko) 2003-11-07
CN1533273A (zh) 2004-09-29
RU2003129233A (ru) 2005-02-10
EP1372636B1 (en) 2006-06-28
PT1372636E (pt) 2006-09-29
NO20033809L (no) 2003-10-23
CY1105468T1 (el) 2010-04-28
PL373376A1 (en) 2005-08-22
BR0207519A (pt) 2005-03-08
HRP20030775A2 (en) 2005-02-28
MXPA03007655A (es) 2003-12-04
DE60212813T2 (de) 2007-01-18
HUP0402115A2 (hu) 2005-02-28
EE200300413A (et) 2003-12-15

Similar Documents

Publication Publication Date Title
ES2269769T3 (es) Terapia de combinacion ee comprende zd6474 y un taxano.
ES2552163T3 (es) Profármacos de triptolida
MX2008013105A (es) Analogo de camptotecina con anillo e "basculante", estable en lactona, novedoso, y metodo para su fabricacion y uso.
CN106279321A (zh) 吉西他滨ProTide乏氧活化前药及其应用
CN101935336B (zh) 一类水溶性紫杉烷类药物的制备方法和应用
US7687487B2 (en) Camptothecin-analog with a novel, “flipped” lactone-stable, E-ring and methods for making and using same
US20130317048A1 (en) Combination comprising paclitaxel for treating ovarian cancer
US20040143004A1 (en) Metronomic dosing of taxanes
JP2011517455A (ja) C(10)エチルエステルおよびc(10)シクロプロピルエステル置換タキサン
ES2211374T3 (es) Dosificacion metronomica de taxanos para inhibir el crecimiento tumoral.
ES2583091T3 (es) Inhibidores de catepsina C
CN109053782A (zh) 多功能靶向免疫小分子抗癌药枸橼酸Bestazomib及其制备方法与应用
CN103980341B (zh) 一种氨基酸丹参酮酚酯衍生物及其制备方法
JP6488280B2 (ja) タキサン系化合物を含有する抗腫瘍剤及び抗腫瘍効果増強剤
CN112794852B (zh) 一种含硒有机化合物及其制备方法与应用
CN109553558B (zh) 一种含硒化合物及其抗肿瘤用途
JPH0840903A (ja) 抗癌剤により誘発される末梢神経障害を予防するための医薬組成物
AU2002254048A1 (en) Metronomic dosing of taxanes for inhibiting tumor growth
JP2018527372A5 (https=)
CN104940212A (zh) 地塞米松用于抑制或治疗转移性或耐药性肿瘤的用途
EP1623706A2 (en) Metronomic dosing of taxanes for inhibiting tumor growth
WO2009104152A1 (en) Combination treatment for ovarian cancer
TW201513849A (zh) 藉由合成之帕那司托(panaxytriol)類似物之毒性下降
JP2015199677A (ja) ノギテカン塩酸塩を含有する抗腫瘍剤及び抗腫瘍効果増強剤